3-formylrifamycin sv has been researched along with rifampin in 5 studies
| Studies (3-formylrifamycin sv) | Trials (3-formylrifamycin sv) | Recent Studies (post-2010) (3-formylrifamycin sv) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 8 | 1 | 3 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | 3-formylrifamycin sv (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, M; Ogata, H | 1 |
| Chen, JK; Hou, YH; Ji, BH; Lu, XZ; Ni, GX; Tang, QK; Wang, SY; Zhou, DH | 1 |
| Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK | 1 |
| Kotecha, JS; Rathod, IS; Savale, SS; Shah, PB; Shah, SA; Shishoo, CJ | 1 |
| Li, W; Wang, J; Yan, ZY | 1 |
1 trial(s) available for 3-formylrifamycin sv and rifampin
| Article | Year |
|---|---|
Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1985 |
4 other study(ies) available for 3-formylrifamycin sv and rifampin
| Article | Year |
|---|---|
Determination of rifampicin and its main metabolites in human plasma by high-performance liquid chromatography.
Topics: Adult; Chromatography, High Pressure Liquid; Humans; Male; Papaverine; Rifampin; Rifamycins; Tuberculosis | 1988 |
Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
Topics: Animals; Humans; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Mycobacterium Infections; Mycobacterium leprae; Mycobacterium lepraemurium; Rifampin; Rifamycins | 1986 |
Stability of rifampicin in dissolution medium in presence of isoniazid.
Topics: Antitubercular Agents; Chromatography, Thin Layer; Drug Compounding; Drug Stability; Hydrochloric Acid; Hydrogen-Ion Concentration; Isoniazid; Regression Analysis; Reproducibility of Results; Rifampin; Rifamycins; Sensitivity and Specificity; Solubility; Spectrophotometry, Ultraviolet | 1999 |
Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Chromatography, Supercritical Fluid; Drug Contamination; Reproducibility of Results; Rifampin; Rifamycins; Solvents; Temperature | 2015 |